2022 START-UPS

4basebio is focussed on accelerating the development and manufacturing of safer and more efficient viral and non-viral gene and cell therapies, mRNA and DNA vaccines, and gene editing, by offering access to its synthetic DNA technology and/or its...

The privately held precision immunotherapy company Alithea Bio UG was founded in 2019 in Freiburg, Germany. Its main goal is the support innovativations like TCR T cell therapy and cancer vaccines. Alithea is partnering its highly sensitive and...

Allarta Life Science Inc. is a regenerative medicine company located in Ontario, Canada, with a platform for immune privileged delivery of therapeutic cells and biologics. Allarta’s first targets are an MSC therapy, and a cell-based therapy for Type ...

anicells accelerates and facilitates the early phase go-to-patient process of cell and gene therapy products. We work closely with you guiding your go-to-patient strategy by offering regulatory support, translating and developing your research into...

At Annogen we use our SuRE technology to identify regulatory DNA elements to be used for controlled (therapeutic) gene expression. We establish databases in which we functionally annotate millions of non-coding sequence variants for their effect on...

Arcanabio develops technologies and offers state of the art diagnostics services that allow for ultra fast screening of hard to detect DNA data. We provide our clients with a complete digital biosurveillance platform and dna testing service where...

Assurea is a firm known for quality compliance and Data Integrity expertise within novel therapies in the global life sciences industry. We have built a model that is collaborative, flexible and accelerates the path forward for our partners to serve ...

ATMPS Ltd has developed Hataali with the aim to increase the availability of life saving cell and gene therapies worldwide.Hataali is a unique, patent pending, blockchain based, vein to vein cell orchestration platform, providing  full chain of...

Autolomous LTD is the market leading developer of critical manufacturing management systems for cell and gene therapies. Autolomous internationally deploys fully integrated, digitized and automated supply chain software solutions. These solutions...

Bionamic is a software platform for drug research and development. The platform is built from the ground up to empower researchers to accelerate the discovery and development of antibodies and other biomolecules. Bionamic is used as a single source...

BIOTTS S.A. is a Polish biotechnology company that develops proprietary drug technologies and drug formulations in the fields of oncology, diabetology and dermatology. Based on unique manufacturing technologies and new approach to substance...

Carcinotech is a MedTech Contract Manufacturing organisation with expertise in manufacturing 3D printed mini tumours using patient-derived cancer stem cells, primary cells and established cell lines. Carcinotech’s advanced models provide a platform...

History of CASC8 CASC8 bvba was established in June 2016 by Prof. Dr. Marc Hendrikx and registered in Keerbergen (Belgium), in order to obtain and harbour the European patent 2 258 833 B1 describing the Cardiac Atrial Appendage Stem Cells or CASC...

CellEctric is the next evolutionary step in mammalian cell manipulation. The technology allows the continuous processing of cell suspensions while selectively permeabilizing or disintegrating targeted subsets by electromagnetic manipulation. The...

Cellected provides innovative stem cell services to help accelerate your CLD processes. Our platform uses a data-centric approach, focused on QC.  Our processes are built around automation, thorough validation and a deep understanding of stem cell...

CELLORAMA, Milton, MA, USAProtect and Discover Cells with Novel TechnologiesCELLORAMA was established in 2020 to provide technologies for a healthy and safe environment for patients ‘samples in the lab. We bring solutions to protect sensitive and...

Cenya Imaging BV is addressing the need to measure the biodistribution of cell therapies in humans and other species by developing Cenya BEACONs, an imaging agent. BEACONs can passively label a wide range of cell types (eg dendritic cells, T...

ClexBio is a regenerative medicine company developing novel tissue-engineered solutions to treat various clinical conditions. The first product in the company’s pipeline is a human acellular vein graft to restore valve function and permanently treat ...

Complement Therapeutics (CTx) is an early-stage biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases as well as developing a unique quantification methodology, the Complement Precision...

C-Path B.V, known as Connected-Pathology, was founded in 2021. Connected-Pathology provides a full suite of preclinical and clinical pathology services. These include conventional pathology, molecular pathology, laboratory animal pathology, and...

Established in 2020, Copner Biotech is a biotechnology company based in Wales, with its main focus in 3D cell culture and associated technologies. What started as an initial concept of next generation 3D printing technology, has gone from strength...

We are developing an approach for human natural killer (NK) cell immunotherapy that involves an off-the-shelf CAR NK cell that enables the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Our NK cell...

Bringing a new Life Sciences product, for example a new drug, to market costs Life Sciences comapnies more than 2bn USD for Research, Development and Manufacturing. These costs are unsustainable and incompatible with delivering affordable health...

Digi.Bio is a digital biology company working at the intersection of biology, computation and engineering to develop cheaper, faster, and smarter automation tools that accelerate life science discoveries. Today, Digi.Bio is building a bench-top...

Drishti Discoveries is an early-stage gene therapy company building a platform to develop disease-modifying treatments for rare diseases. Using bioinformatics and machine learning tools we are identifying novel targets and developing drug candidates ...

Overcoming current in vivo gene therapy vectors limitations, EG427 is a biotech company developing a sole-in-class, non-replicative Herpes Simplex Virus 1 (HSV-1) based platform allowing multiple administration and selective delivery of large...

​​​Elastrin Therapeutics is a US-based biotechnology startup leveraging a platform technology to develop medicines that restore hardened and damaged arteries and tissues by specifically targeting degraded elastic fiber. Elastin fibers are critical...

Biomedical data and software solutions for the age of machine intelligenceWe specialise in providing tools and services to solve problems at the intersection of medicine and ML/AI. From data acquisition, building infrastructure and processes to...

Erbi Biosystems develops high-performance novel cell bioprocessing technology that rapidly impacts the speed of process development.  The Breez™ is a fully automated, sterile, single-use dose-scale bioreactor includes online sensing and controls...

evorion biotechnologies has developed its innovative CellCity System and high-tech tools that enable multi-modal analyses of thousands of cell-cell interactions in a 3D microenvironment at single-cell resolution. For the first time, researchers can...

​​​The company is focusing on customized logistics for Biotech’s, startups and distribution of ATMPs products. ExoZelle is Embracing together the logistics challenges of ATMPs and Biologics: Organs, Genes, Tissues & Cells

StemCellCare insurance can provide cover should a child (or their biological sibling) need to use their stored stem cells for treatment. StemCellCare insurance can give parents peace of mind and flexibility with a lump sum contribution towards the...

Plastic waste is one of the major challenges for researchers and biopharmaceutical manufacturers in terms of environmental footprint reduction. After usage, single-use consumables are usually autoclaved and then burnt – releasing millions of tons of ...

Helex is accelerating next generation CRISPR based cell and gene therapy companies to market through its technology that enables better control over genome editing by precision engineering the programmable component of the CRISPR/Cas system- the...

At ImmuneWatch we want to accelerate the development of T-cell based diagnostic tools and therapies. Our mission is to make immune repertoire data interpretable and actionable by annotating T-cell receptors in a clinically meaningful way. We offer...

inoCells provides a unique stem cell therapy and banking to rejuvenate the ovary of infertile patients whose ovaries have low quality and quantity of eggs. inoCells provide this patient population a high chance to become pregnant with their own...

KML Vision, an award-winning DeepTech company, provides intuitive and accessible software solutions specifically designed for the life scientists on the IKOSA Platform.Focused on microscopy, KML Vision creates with IKOSA a disruptive user experience ...

Lentivirus is commonly used as a vector for gene addition due to its ability to deliver relatively large payloads that stably integrate into the host genome.  This vector is clinically and commercially employed in direct gene therapy applications or ...

Limula SA is a Life Science company based in Lausanne, Switzerland. Our company was established with the explicit mission to help bring CGT to the patients in need, at reasonable cost, wherever they are. To achieve this goal, our multidisciplinary...

lino Biotech AG is the world’s only company specialized in focal molography – an entirely new method for measuring molecular interactions in living cells or crude biological samples. The broadly patented technology offers label-free detection assays ...

Luminary is a clinical-stage gene modified cellular therapy development company. We expect to launch our first clinical trial in Q1-2022 with a novel 3 receptor Ligand CAR designed to overcome antigen escape. The primary focus of the company is...

M13 Therapeutics is a MIT-founded gene therapy startup developing a next-generation platform for redoseable in-vivo gene delivery. Our company is harnessing the human phageome to engineer a diverse set of nanoparticles, called phage-derived...

Matricelf is a biotechnology company in the field of tissue engineering. The company develops a platform for autologous (personal) 3D printing of tissues and organs that significantly reduce the risk of implant rejection. Using a single biopsy from...

Medace is committed to bring the (bio)medical innovations (ATMPs, biopharmaceuticals & medical devices) of start-ups and academics to the market and patients faster. By sharing our expertise, infrastructure, Quality Management System (QMS), and...

Mendel Partners help Advanced Therapies and Rare Disease Biotech clients across the globe to attract best-in-class investors & leadership teams that make meaningful differences to patients & shareholders alike.All of our Biotech Advisors...

MicrofluidX is tackling the problems of process control, scalability, and cost associated with cell bioprocessing, in particular for autologous cell and gene therapy. Its automated, closed bioprocessing platforms allows scientists to easily carry...

MyCellHub is the European leader in biomanufacturing process digitalisation strategy, helping democratise access to innovative therapies by supporting those who develop them. Digital lab and cleanroom workflows now play a critical part in therapy...

Mytos develops cell culture automation technology to accelerate drug discovery. Our machines use robotic automation to maintain and expand adherent and suspension cultures, allowing teams to save time & resources on cell culture.

Nanotein Technologies, Inc. is a fast-moving startup company from Berkeley, California, that has innovated a best-in-class T cell activation and expansion reagent for the CAR-T industry. This reagent generates more T cells per unit time, while...

Neobe Therapeutics is an early stage startup spun out of a collaboration between Deep Science Ventures and Cancer Research UK to address tumour microenvironment constraints to therapeutic efficacy. Only around 20% of patients with solid tumors are...

NETRI is a company developing innovative technologies for the pharmaceutical industry. Its patented organ-on-a-chip technologies allow the creation of standardized, human and predictive in vitro models. This allows to anticipate the efficacy of an...

Novasign uses advanced machine learning algorithms (mainly hybrid models) to better and faster describe bioprocesses. Our customers are mainly in early stage development (up- and downstream) aiming to optimize their bioprocesses with less...

OncoBone Therapeutics is a Finland-based start-up company developing IP for its UK-based parent company OncoBone Ventures. The focus is to develop novel therapies for cancer patients with currently incurable bone metastasis. The therapies will be...

Patient-derived tumoroids are becoming invaluable for fundamental and translational cancer research and hold great promise for functional precision medicine. Live-cell imaging is a powerful tool for monitoring in vitro drug responses in tumoroids...

OXvax Ltd. is a spin out company from the University of Oxford focused on the development of an advanced next generation dendritic cell vaccine platform for the treatment of solid tumour cancers.The Company’s technology is based on intellectual...

​​​​PixelBiotech GmbH is a spin-off company from German Cancer Research Center in Heidelberg. Our mission is to deliver cutting-edge technologies for targeted RNA and DNA studies, creating opportunities for scientists to advance research in cell and ...

Pleco Therapeutics is a Dutch private limited company, established to develop a portfolio of therapies in the field of cancer medicine. Pleco utilises a global network of academic centres and contract research organisations to test highly-efficient...

Reflection Therapeutics is a Cambridge-based seed-stage cell therapy company developing transformative targeted, autologous Treg cell therapies for serious autoimmune and neurodegenerative diseases.Regulatory T cells are white blood cells that...

REM Analytics is developing the next generation of microbiome analysis. We developed a unique technology for profiling human microbiomes quantitatively and comprehensively with strain level resolution. Using our analytical know-how, we provide...

RheaVita provides continuous freeze-drying technology for (bio)pharmaceutical products resolving the shortcomings related to traditional batch freeze-drying, but also providing new opportunities. Our technology integrates all freeze-drying process...

Rinri Therapeutics Ltd. is a therapeutic discovery and development company working to develop advanced therapies for hearing loss, a global condition affecting millions with no approved therapies and poor patient outcomes.  Rinri is leveraging its...

Current gene therapies are mostly limited to plasmid-based and Adeno-associated virus variants with inefficient response rates and limited use.  Better viral delivery methods would expand the available gene therapy tool kit to produce precision...

Sarcura develops a cutting-edge device platform to scale global manufacturing capacity, enabling cost effective and safe cell therapies. We will transform existing manufacturing paradigms by using semiconductor technology to bring bioprocess control ...

At SEED Biosciences we make DISPENCELL, an automated laboratory instrument designed for fast, easy, and gentle single cell isolation.DISPENCELL is a pipetting robot designed to be compact, gentle, and intuitive, yet compliant with the most stringent ...

Semarion is a spin-out company from the Cavendish laboratory at Cambridge University. We are reimaging adherent cell assays through our proprietary SemaCytes® microcarrier platform. These flat carriers are developed using microchip fabrication...

Single Cell Discoveries is a dedicated CRO for single-cell sequencing and spatial transcriptomics services. As your one-stop-shop, we help you with the design of your experiment, we process your samples and we provide data analysis services.With our ...

At Sorbus Biomedical, we develop technical solutions for cell cultivation that goes beyond the capabilities of current day standardized equipment. Overcoming limitations of traditional equipment in the lab environment, our cultivation technology...

Stem Genomics is a French biotechnology specialized in designing innovative testing technologies dedicated to stem cells. We are a spin-out of the Institute of Regenerative Medicine and Biotherapy (IRMB) and co-founded by Prof. John de Vos and...

StemInov is a clinical stage spin-off from CHRU of Nancy and University of Lorena (UL) that develops an off the shelf cell therapy treatment in the field of inflammatory pathologies with a focus on critical care. More than a new compound, our...

StemSight Oy is an early-stage biotech company developing of-the-shelf therapies for corneal blindness from induced pluripotent stem cells (iPSCs). Our first product aims to cure limbal stem cell deficiency, a rare but severe condition resulting...

TestAVec was set up in 2017 in response to the need for a rapid, reliable and robust human-relevant non-clinical model and methodology with which to assess the risk of potential carcinogenicity of gene therapies, replacing rodent tests which are...

TissueGUARD GmbH is a biotechnology company founded in 2019 that develops and produces hydrogel-based medical devices for tissue and organoid engineering. TissueGUARD’s patented technology allows both the formation of tissue or organoids and their...

The Sample Network is a human biosample acquisition and collection company focused on supporting early stage research.  Research often requires highly specialised sample requirements to address hypotheses, which is often unaddressed by traditional...

Trince, a spin-off company from UGent is dedicated to delivering molecules into cells, both in vitro and ex vivo.

Building on a foundation of expertise in cancer research and medical device development, Verinnogen looks to tackle one of the biggest unmet technological needs in pre-clinical cancer research: quick and accurate estimation of subcutaneous tumour...

Visicell, “GPS for cell therapy”, provides non-invasive, imaging-based cell tracking solutions to customers in a multi-billion-dollar cell therapy industry. Our patent-pending solutions arm users with early and rapid clinical information for timely...

Vivan Therapeutics, a UK based company, offers personalised cancer therapeutics utilising technology developed at and in partnership with Mt Sinai Medical Centre.  We identify personalised cancer treatments for patients based on their tumour...

Yoni Solutions is a Healthcare Company exploiting the untapped potential of vaginal microbiome to improve the treatment of recurrent vaginal infections and the outcome of In Vitro Fertilization procedures after multiple failures.Lack of information...